Bruce Robinson

*** ******** ** • Princeton, NJ • 609-***-**** • acrdrl@r.postjobfree.com

August 23, 2015

Hello MedStaff,

Bruce Robinson writing.

Formerly Medical Director/Brand Strategist with Fingerpaint, my purview over $6.3 million in SOWs for pharma marketing ranged from extant products seeking a last hurrah before patent expiry (Mallinckrodt’s Exalgo) to new and exciting BTD therapeutics (Xartemis). All present the inherent thrill of positioning brand and client identity through high-sciences core marketing messaging, upper management buy-in across the KPIs, FDA regulatory challenges to a medical-legal imprimatur, reimbursement tactics, and crafting of deliverables for optimum engagement. Positioning for clients included Payer strategies, formulary placement, recommendations for pricing maturation, future evergreening, as well as label language/indication that align CTs for best indication and widest prescribing audience. I find insights not readily apparent, and have received a commendation for changing an FDA-approved label’s DDI for best medical sciences.

Presently with Havas, I supervise both copy and strategy for BLINCYTO™ (Amgen), a recently BTD immuno-oncology therapeutic for acute lymphocytic leukemia. My team (accounts, strategists, creatives, PMs and art) lands dead center on brand positioning, consumer/HCP assessments, medical content development with unparalleled engagement, FDA regulatory overview, and SOW rollout. BLINCYTO is about the tenth oncology therapeutic which I have been pleased to bring to market or re-energize, from a payer and prescriber perspectives. I am well versed in numerous therapeutic categories and their respective disease states.

I would love to share my portfolio with you to demonstrate DTP writing skills for all formats in media, and styles of writing, including CME and regulatory

Thank you for reading.

Best,

Bruce Robinson

267-***-****

Bruce Robinson

620 Rosedale Rd • Princeton, NJ • 609-***-**** • acrdrl@r.postjobfree.com

SUMMARY OF QUALIFICATIONS

Excellent strategizing, research, and conceptualization skills for therapeutic market placement, launch, and brand life story

Ability to relate and articulate effectively to clients and staff

In-depth therapeutic clinical sciences expertise with focus on analgesics, cardiology, oncology, internal medicine

WORK HISTORY

Havas Lynx/H4B, New York, NY • Director Medical Strategy/Copy (Consultant) • Present

Amgen’s FDA BTD oncology product BLINCYTO and Pfizer’s IBRANCE. Responsible for: RFP writer/strategist, PITCH presenter, KPI buy-in, market testing and messaging, CVAs, speakers decks, KOL development and ad board creation, publications roll-out, symposia and national meetings (ASCO) representation, creative messaging, unbranded campaigns, patient conversion and adherence tactics, payer acceptance. Oversee two teams.

Fingerpaint Marketing, Saratoga Springs, NY • Medical Director • January 2013 to February 2014

Medical Marketing and Strategy Supervision for clients’ therapeutics ensuring alignment to SOWs, strategizing market planning towards enriching client’s core values and product story, with on-boarding the complexity of the molecule and disease states through innovative simplicity across the Fingerpaint community. Positioning for clients included Payer strategies, formulary placement, and optimum contractual pricing plans. $6.3 million in deliverables with six new launches, three FDA-designated Breakthrough Therapies. Resource for core marketing messaging and buy-in across client upper management to KPIs. Leveraged high-sciences to tactics based on the therapeutics’ Clinical Trials profiles to assist in language for the label and FDA regulatory review for marketing roll-out. Final filter on all copy from Copywriters and Creative towards alignment with brand story and functionality of deliverable. Mentor to junior writers. Developer medical content specific to brand or disease state when applicable to unbranded effort. Key participant through all medicolegal client reviews both in person and conferenced. Agency representative as “owner” and point person to the client with Account and Creative Teams.

Kaplan Thaler Group, NYC, Senior Medical Copywriter • May 2012 to January 2013

Freelance writer and creator scientific content for DTP/DTC pharmaceutical marketing ventures in a variety of digital formats, including: Web sites, e-detailing, MOAs, and banners.

Ignite Health, NYC, Medical Copywriter • April 2009 to May 2012

Writer, developer, “owner” scientific and creative content for DTP/DTC pharmaceutical marketing ventures in a variety of digital formats, including: Web sites, mobile apps, e-detailing, MOAs, banners. Specifics: decisive role in development of Vertex’s INCIVEK Mobile App (DTP/hep C), reworked the Interactive Treatment Algorithm and Drug Interactions channels necessitating updates to the INCIVEK PI as well as the Treatment Management Guide. Received commendation from Ignite Health (Vertex Board of Trustees enamored of the effort). IA, UX development, and writer Istodax and Revlimid DTP websites (Celgene). Writer therapeutic overviews for team on-boarding to new disease states and therapeutic competitors vs. opportunities, including the pertinent etiologies. Messaging and strategy contributor to team’s client’s products development, marketing position, and key deliverables optimizing KPIs and overall product market consistency. Numerous on-locale medico-legal reviews as author/writer. Pitch contributor as sciences expert. Reduction in Force layoffs.

Bruce Robinson

620 Rosedale Rd • Princeton, NJ • 609-***-**** • acrdrl@r.postjobfree.com

Creative Communications, Freelance Medical Copywriter • 1996 to Present

Senior Medical Writer for medical/pharmaceutical sciences marketing and healthcare education communications. Multiple media including Web sites, e-format, video, and print. Symposia didactic acquisition, editorial, and project management; grand rounds PowerPoint presentations and slide kits; clinical sciences/product monograph writer (ProSom, Solumedrol); patient education literature in numerous categories; peer-reviewed journal article writer (Pain Management in Bone Cancer for Excellence in

Pharmacotherapy). Direct mail and drug promotional launches. Recent projects: digital aids for Varivax, Pedvax, and Merck vaccines professional and detail mobile apps. Conceptual and creative DTP copy

www.uloric.com. Vimovo digital detail aids, vanillas, and e-learning sites. PfizerPro Genotropin DTP Web sciences writer. PfizerPro Pristiq DTP Web sciences writer. Rapid immersion/familiarity all therapeutic categories.

The University of South Carolina, Columbia, SC • Research Associate • 1990 to 1993

Bench-top Molecular Research Associate. Employed current protocols of recombinant DNA technology: radioactive hybridizations, high-pressure liquid chromatography, southern gels, plasmid preps, PCR, tissue culture, in-situ fluorscein hybridizations, and histological staining/EM examination.

Elsevier Science Publishing/Healthways Communications, New York, NY • 1986 to 1989

Managing Editor, Pharmaceutical Marketing. Created didactic print and video sales and educational tools for pharmaceutical industry. Writer of continuing medical education (CME), product monographs, grand rounds slide programs, patient education literature. Accountable to manufacturer’s Project Directors and sensitive budget and medico-legal constraints, as well as physician authors. Supervised three editors’ multiple projects, including performance, timeliness, educational content, turnaround, and budgets.

EDUCATION

Columbia University • 1983 • BA, English

The University of South Carolina • 1989-1993 • BS, Molecular Biology

Medical University of South Carolina • 1996 • Three years MD/PhD program

ACHIEVEMENTS

Recipient Howard Hughes Fellowship: “Mus Androgen-Inducible Genes” grant publication, 1993

Languages: English and French

Contact this candidate